23 Oct 2004
As 1st Commercial Plant Nears Completion, Cyclics Plans Expansion and Begins Global Search for 2nd Larger Plant
Company Notes Rapid Growth in Demand for New CBT® resin is Driving Expansion Plans
Düsseldorf, Germany - October 23, 2004 – The Cyclics Corporation announced the initiation of a formal search to site a second, world scale plant for the production of CBT® resin. Although the search currently is focused primarily in North America and Europe, other regions will also be considered. Proximity to raw materials, low raw material and energy costs, availability of skilled labor, good transportation routes and attractive financial incentives are among the key criteria Cyclics is evaluating for siting the second plant. Davy Process Engineering (www.davyprotech.com), the engineering firm that led the design and construction of Cyclics’ first plant, in Schwarzheide, Germany, will assist in the site qualification process.
The announcement comes as Cyclics nears completion of its first commercial plant, with a capacity of 2500 metric tonnes (5.5 million pounds). Located in Schwarzheide, Germany, the plant is scheduled to be producing commercial products in the first quarter of 2005. Greater than 50% of the initial nameplate capacity is under contract and a strong pipeline of development projects has led Cyclics to take steps to double the capacity to 5000 metric tonnes (10 million pounds) at the Schwarzheide plant late in 2005.
“The tremendous growth in demand we are seeing for our products has given us the confidence to launch this search,” said Ted Eveleth, CEO of Cyclics Corporation. “We are experiencing very encouraging developments in high-volume applications.”
“It is exciting to see the Schwarzheide plant nearing completion,” said Dr. Gary Faler, Chief Technology Officer of Cyclics Corporation, “Our enthusiasm is shared by our customers who have played an invaluable role in helping us develop our first commercial products, our financial backers who have financed the plant and all of our employees in both North America and Europe.”
Reader enquiries
Cyclics Corporation
2135 Technology Drive
Schenectady, NY 12308
U.S.A.
Notes for editors
Cyclics Corporation, headquartered in Schenectady, New York, U.S.A. and its wholly owned subsidiary, Cyclics Europe GmbH based in Schwarzheide, Germany, manufacture innovative plastics that offer breakthroughs in processing, making new products possible and changing the economics of existing ones. The water-like processing viscosities of Cyclics’ engineering thermoplastic products offer improvements in performance and productivity for structural composites, compounding, casting, nanocomposites, coatings and rotational molding. Cyclics has alliances with Dow Automotive, BASF, Alcan Composites, The P-Group and Davy Process Technology.
® CBT is a Registered Trademark of Cyclics Corporation.
Related images
Cyclics Plant Nears Completion, Expansion Planned, Search for 2nd Plant Begins
Düsseldorf, Germany – As Cyclics Corporation nears completion of its first commercial plant in Schwarzheide, Germany, the company has already begun its search for a second production plant to manufacture its patented CBT® resins. The company’s first plant is being constructed on the large BASF manufacturing complex outside of Dresden. The Schwarzheide plant (shown above during construction in late September) is expected to be finalized by the end of 2004 and will have an initial annual capacity of 2,500-metric tons (5.5-million pounds), with plans to begin doubling that capacity in 2005. Beyond utilizing BASF’s existing infrastructure at the site, Cyclics will also benefit from having its key feedstock, polybutylene terephthalate (PBT) resin, produced by BASF at the location. Currently, more than 50% of the initial nameplate capacity at the Schwarzheide plant is already under contract.
Editorial enquiries
Meg MacClarence
Cyclics Corporation
Alan Flower
EMG